Skip to content

Erectile Dysfunction Progression After Percutaneous Coronary Angiography: Is Residual SYNTAX Score a Predictive Marker

Erectile Dysfunction Progression After Coronary Angiography: Is Residual SYNTAX Score a Predictive Marker

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07010913
Enrollment
100
Registered
2025-06-08
Start date
2025-02-14
Completion date
2025-10-31
Last updated
2025-06-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary Arterial Disease (CAD), Erectile Dysfunction

Keywords

syntax score, residual syntax score, erectile disfunction

Brief summary

Participant Information Sheet Dear Participant, Investigators would like to invite participants to participate in a research study and explain what it involves. Please take a few moments to read the following information carefully. If you have any questions, feel free to ask us at any time. What is this study about? This study aims to understand how coronary angiography (a heart procedure you've recently had) may affect erectile function over time. Investigators are especially interested in whether the degree of blockage in participants' heart vessels and how well participants were treated during the procedure affect erectile health. What will participants be asked to do? If participants agree to take part: Investigators will ask participants to answer a short questionnaire with five questions about their erectile function. This will happen once while participants recover in the hospital and again 6 months later. Each question is rated on a simple scale from 0 to 5. Investigators will also collect some medical information, such as your age, weight, height, blood test results, details about your heart condition, other health problems, and the medications participants are taking. All information will be kept confidential and used only for scientific purposes. Participants' identities will not be revealed in any part of the study. Do participants have to take part? No. Participation is completely voluntary. Participants can choose not to take part, and you can also stop at any time without giving a reason. Participants' decisions will not affect their medical care in any way. Will there be any extra tests or costs? No. This study does not involve extra tests beyond regular medical care, such as blood tests or heart monitoring, and participation is free. How long will the study last? The study will last approximately one year. Once it's completed, participants are welcome to ask for the results from our institution. Who is conducting the study? The study is being conducted by: Assist Prof Dr. Timucin Sipal (Urology Department) Assist Prof Dr. Caglar Alp (Cardiology Department) You can contact them anytime using the phone number we have provided. What happens next? If participants are happy to participate, please sign the attached consent form. Sincerely, The Research Team

Interventions

None listed

Sponsors

Kırıkkale University
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
MALE
Age
20 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* Having a First heart attack

Exclusion criteria

* History of previous coronary intervention * Neurological condition * Previous pelvic surgery * Aged less than 20 and more than 70 years * Having an additional heart attack during the follow-up period * Excluding from the study * Having no sexual life

Design outcomes

Primary

MeasureTime frameDescription
Erectile functioning changes following percutaneous coronary intervention from baseline through 6 monthsfrom February 2025 to September 2025Participants' answers will decrease or increase from the baseline score of 0 to 25 on the IIEF questionnaires following percutaneous coronary intervention after a heart attack.

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026